Why Some Melanoma Patients Face Worse Prognoses, According to New Karolinska Research

Each year, more than 6,000 Swedes receive a melanoma diagnosis, a skin cancer that can become deadly if not caught early. While every case is unique, outcomes vary dramatically among patients.

A recent doctoral thesis from Karolinska Institutet delves into the biological reasons behind these differences. The research identifies specific genetic mutations and immune?system interactions that correlate with more aggressive disease and lower survival rates.

The study also examines how tumor location, thickness, and patient age influence prognosis, offering clinicians clearer markers to predict which melanomas are likely to progress.

By pinpointing the factors that drive poorer outcomes, the findings could help doctors tailor treatments more precisely, potentially improving survival for high?risk melanoma patients.